It is a life sciences private limited company based in Chennai, Tamil Nadu, India, established in 2022.
2022 | Chennai, Tamil Nadu, India | ActiveNavitas Life Sciences Private Limited, a active private limited company, was established on 20 May 2022 in Chennai, Tamil Nadu, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U73100TN2022PTC152401. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹10.00 K .
Employing 715 professional, Its leadership includes Ranganathan Praveen (Director), Priya Jebarani Aldam (Director). Past directors included Ranganathan Praveen, Vedamirtham Venkatesan. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Cee Dee Yes, Fayola Twrs, Vi Flr, 56/3A Radial Road, 200 Feet Road, Pallikaranai, Chennai, Tamil Nadu, 600100.
U73100TN2022PTC152401
152401
20 May 2022
₹1.50 M
₹10.00 K
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Navitas Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ranganathan Praveen | Director | 31 Jul 2022 | Current |
| Priya Jebarani Aldam | Director | 20 May 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Dec 2023 | Past |
| Pramod Abcsdd | Director | 31 Jul 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Navitas Life Sciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 52.47% increase. The company also saw a substantial fall in profitability, with a 31.59% decrease in profit. The company's net worth Soared by an impressive increase of 68.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Navitas Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Navitas Life Sciences has a workforce of 715 employees as of May 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Navitas Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Navitas Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Navitas Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Navitas Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
The activity Ranganathan Praveen was appointed as a Director was appointed as a Director on 31 Jul 2022 & has been associated with this company since 3 years 5 months . was completed.
The activity Priya Jebarani Aldam was appointed as a Director was appointed as a Director on 20 May 2022 & has been associated with this company since 3 years 7 months . was completed.
Navitas Life Sciences Private Limited was registered on 20 May 2022 with Roc Chennai & aged 3 years 7 months as per MCA records. was recorded as a recent event.
/PRNewswire/ -- ThoughtSphere, a fast growing, cloud-based clinical data hub and analytics SaaS company, today announced that Navitas Life Sciences, a full....
/PRNewswire/ -- Navitas Life Sciences, a TAKE Solutions Enterprise today announced the acquisition of US based niche full service CRO and health research....
/PRNewswire/ -- Navitas Life Sciences, a TAKE Solutions Enterprise today announced that it will be acquiring Life Sciences services player, DataCeutics in....
The CIN of Navitas Life Sciences Private Limited is U73100TN2022PTC152401.
Navitas Life Sciences Private Limited is headquartered at Cee Dee Yes, Fayola Twrs, Vi Flr, 56/3A Radial Road, 200 Feet Road, Pallikaranai, Chennai, Tamil Nadu, 600100.
Navitas Life Sciences Private Limited was incorporated on 20 May 2022.
The current directors of Navitas Life Sciences Private Limited are
The primary industry of Navitas Life Sciences Private Limited is Professional, Scientific And Technical.
Navitas Life Sciences Private Limited is unlisted.
The authorized capital of Navitas Life Sciences Private Limited is ₹1.50 M, and the paid-up capital is ₹10.00 K .
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX